De Castro, Khamell M.
HRN: 23-70-43 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/10/2023
09/17/2023
IV
500mg
Q8
AGE
Checking Final Appropriateness
09/11/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/11/2023
09/17/2023
PO
1.5 G
Q8
Infected Wound,
Checking Final Appropriateness
09/11/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/11/2023
09/17/2023
IVTT
600mg
Q8
Infected Wound
Checking Final Appropriateness
09/11/2023
FLUCONAZOLE 150MG (CAP)
09/11/2023
09/17/2023
PO
150mg
Od
Fungal Infection Right Foot
Checking Final Appropriateness
09/13/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/13/2023
09/19/2023
IV
4.5g
Q8
Infected Wound, Right Digit
Checking Final Appropriateness
09/13/2023
METRONIDAZOLE 500MG (TAB)
09/13/2023
09/19/2023
PO
500mg
TID
AGE
Checking Final Appropriateness
09/17/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/17/2023
09/24/2023
IV
600mg
Q6
Cellulitis
Checking Final Appropriateness
09/23/2023
CEFIXIME 200MG (CAP)
09/23/2023
09/30/2023
ORAL
200mg/cap
BID
Infected Wound Both Feet
Checking Final Appropriateness